Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(60%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(4)
Completed(1)

Detailed Status

Recruiting3
Completed1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed120%
not_yet_recruiting120%
recruiting360%

Recent Activity

3 active trials
Showing 5 of 5
not_yet_recruiting

Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank

NCT06629363
completed

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.

NCT04885452
recruiting

Constitution of a Biobank for Studies Related to Organ Transplantation (Lyon Centaure Biocollection)

NCT04687865
recruiting

Viral Epidemiology of Bronchiolitis After Nirsevimab Implementation and Respiratory Evolution in Infants

NCT06636955
recruitingnot_applicable

Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis

NCT04779593

Clinical Trials (5)

Showing 5 of 5 trials
NCT06629363

Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank

Not Yet Recruiting
NCT04885452

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.

Completed
NCT04687865

Constitution of a Biobank for Studies Related to Organ Transplantation (Lyon Centaure Biocollection)

Recruiting
NCT06636955

Viral Epidemiology of Bronchiolitis After Nirsevimab Implementation and Respiratory Evolution in Infants

Recruiting
NCT04779593Not Applicable

Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis

Recruiting

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5